By Scott Scanlon
There are many threads to pull when it comes to determining why prescription drugs cost as much as they do – and how they can be made more affordable for the governments and billions of people who depend on them, at least in part, for their health and wellness. I looked to hit the high points with the main story in this week's Refresh coverage, but found several other stories and sources worth noting for readers who want more context and the opportunity to dig deeper.Continue reading....
On This Blog
The controversy over expensive new drugs for hepatitis C
Link to research and news articles addressing the high cost of hepatitis C drugs; insurance restrictions - private insurers/Medicaid - and availability of generic versions/India, Egypt and other lower-income countries or through online "buyers clubs"
No comments:
Post a Comment